CH
TVGN icon

CVI Holdings’s Tevogen Bio Holdings TVGN Stock Holding History

CVI Holdings’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,858
Closed -$960K – 451
2022
Q4 		$960K Sell
1,858
-783
-30% -$401K 0.12% 199
2022
Q3 		$1.34M Hold
2,641
– – 0.1% 288
2022
Q2 		$1.32M Hold
2,641
– – 0.1% 316
2022
Q1 		$1.32M Buy
+2,641
New +$1.31M 0.09% 343

Other funds holding TVGN

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CVI Holdings's TVGN Position: Q1 2023 in Review

CVI Holdings sold out of Tevogen Bio Holdings (TVGN) in Q1 2023, closing a stake of 1,858 shares — an estimated $960K sold.

CVI Holdings first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $1.34M in Q3 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

  • CVI Holdings reported no remaining Tevogen Bio Holdings position as of Q1 2023 after selling out during the quarter.
  • CVI Holdings sold 1,858 Tevogen Bio Holdings shares in Q1 2023, an estimated $960K.
  • CVI Holdings first reported a position in Tevogen Bio Holdings in Q1 2022 and held it in 4 quarters.
  • CVI Holdings's Tevogen Bio Holdings position peaked at $1.34M in Q3 2022.
  • 4 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2023.

Based on CVI Holdings's 13F filing for Q1 2023, filed 16 May 2023.